Incyte Corporation Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Published: Jan 14, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) today announced that in connection with the hiring, announced on January 13, 2014, of Hervé Hoppenot as President and Chief Executive Officer, Mr. Hoppenot received an award of restricted stock units (RSUs) to acquire 400,000 shares of Incyte common stock.

Help employers find you! Check out all the jobs and post your resume.

Back to news